Oasmia Pharmaceutical AB (OASMY) Financial Statements
Oasmia Pharmaceutical AB (OASMY) files with the U.S. Securities and Exchange Commission under CIK 0001607245. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2018
- Revenue
- 3.17 million SEK
- Net Income
- -118.01 million SEK
- Total Assets
- 568.08 million SEK
- Net Cash from Operations
- -123.63 million SEK
Fiscal year ended Apr 30, 2018. Latest periodic SEC filing: Sep 14, 2018. Source: SEC filings (EDGAR XBRL). Amounts in SEK.
Open the full financial statements for OASMY in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History